7 results match your criteria: "France. daniel.talon@ufc-chu.univ.fcomte.fr[Affiliation]"
Ann Chir
May 2006
Service d'hygiène hospitalière, CHU Jean-Minjoz, boulevard Fleming, 25030 Besançon cedex, France.
Aim: To compare the performance of various types of airflow system in operating theatre.
Methods: Besançon Hospital has three types of airflow system in operating theatre: laminar (unidirectional) flow, stabilized flow and turbulent flow. We have compared performances of these airflow systems during operations by evaluating several indicators: number of airborne particles, microbial contamination, kinetics of decontamination, rate of mixing and an index of functionality.
J Hosp Infect
June 2004
Service d'Hygiène Hospitalière et d'Epidémiologie moléculaire, 25030 Besançon cedex, France.
In the first week of December 2002, three infants hospitalized in the neonatal department of our hospital had blood cultures positive with Enterobacter cloacae. Screening cultures and genotyping showed that 10 of 25 screened patients also carried E. cloacae and that nine isolates belonged to the same clone as that responsible for all three bacteraemias.
View Article and Find Full Text PDFJ Hosp Infect
May 2003
Service d'Hygiène hospitalière et d'Epidémiologie moléculaire, Centre Hospitalier Universitaire Jean Minjoz, Besançon Cedex 25030, France.
The aim of this retrospective study was to determine whether or not a surgical dedicated cohort facility, mainly dedicated to the care of orthopaedic patients, can control the risk of infection caused by methicillin-resistant Staphylococcus aureus (MRSA). We tested this hypothesis on the orthopaedic surgery ward of a university-affiliated public hospital with 1228 beds by determining whether there was a significant correlation between the colonization pressure exerted by MRSA and the number of cases of acquired MRSA. This was then used as a tool to predict the number of patients contaminated with MRSA in hospitals with and without dedicated cohort facilities.
View Article and Find Full Text PDFInt J Antimicrob Agents
September 2002
Service d'Hygiène hospitalière et d'Epidémiologie moléculaire, Centre Hospitalier Universitaire Jean Minjoz, Besançon 25030, France.
Gentamicin-susceptible, methicillin-resistant, Stapylococcus aureus strains (GS-MRSA) emerged in 1992 in various Parisian hospitals and have subsequently been isolated from all French hospitals. This new GS-MRSA epidemic clone accounted for 50% of MRSA strains in 1996 and for 85% in 2000 in our hospital. We have observed a parallel increase in the prevalence of tobramycin and amikacin-susceptible GS-MRSA (TKS-MRSA).
View Article and Find Full Text PDFDiagn Microbiol Infect Dis
July 2002
Service d'Hygiène Hospitalière et d'Epidémiologie moléculaire CHU, Besançon 25030, France.
We report the first case of catalase-negative methicillin-resistant Staphylococcus aureus. The isolated strain had phenotypic and genotypic characteristics of the major epidemic clone spreading in our region with the exception that catalase activity could not be found.
View Article and Find Full Text PDFPathol Biol (Paris)
October 2001
Service d'hygiène hospitalière et d'épidémiologie moléculaire, centre hospitalier universitaire Jean Minjoz, 25030, Besançon, France.
We reviewed the literature concerning the role of antibiotic use as a risk factor for glycopeptide-resistant enterococci (VRE) infection/colonisation, to enable us to develop measures for preventing the acquisition and transmission of VRE. We found that the length of stay, the number of stays in hospital and the transfer of patients between hospitals and units were all risk factors for acquiring VRE infection. However, analysis of group and individual data showed that there was also a clear link between vancomycin and third-generation cephalosporin use and the prevalence of VRE colonisation/infection.
View Article and Find Full Text PDFClin Microbiol Infect
July 2000
Service d'Hygiène Hospitalière et d'Epidémiologie Moléculaire, Centre Hospitalier Universitaire Jean Minjoz, Besançon, France.
Objective: To determine both the prevalence of group I beta-lactamase-related resistance and the clinical setting in which resistance to expanded-spectrum cephalosporins occurs.
Methods: Isolates of Enterobacter spp. were sensitivity tested to a range of antibiotics, and selected isolates were DNA fingerprinted by pulsed-field gel electrophoresis.